Pure Global

BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95 - INVIMA Registration 24906ad38e3cf35c2fe383a35d58b7dc

Access comprehensive regulatory information for BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95 (BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95) in the Colombia medical device market through Pure Global AI's free database. This medical device is registered under INVIMA analysis ID 24906ad38e3cf35c2fe383a35d58b7dc and manufactured by BECTON DICKINSON DE COLOMBIA LTDA. The device was registered on August 25, 2033.

This page provides complete registration details including product type (REACTIVOS IN VITRO), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.

Free Database
Powered by Pure Global AI
INVIMA Official Data
24906ad38e3cf35c2fe383a35d58b7dc
BD PHARMINGEN™ PE-CY™7 MOUSE ANTI-HUMAN CD95
INVIMA Analysis ID: 24906ad38e3cf35c2fe383a35d58b7dc
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

ANTICUERPOS MONOCLONALES QUE DETECTAN _x000D_ ANTÍGENOS HUMANOS EN CÉLULAS SANGUÍNEAS _x000D_ ASOCIADAS A PATOLOGÍAS ONCOLÓGICAS.

English

MONOCLONAL ANTIBODIES THAT DETECT _x000D_ HUMAN ANTIGENS ON BLOOD CELLS _x000D_ ASSOCIATED WITH ONCOLOGICAL PATHOLOGIES.

Device Classification
Product Type (Spanish)
REACTIVOS IN VITRO
Product Type (English)
REACTIVOS IN VITRO
Registration Information
Analysis ID
24906ad38e3cf35c2fe383a35d58b7dc
Expire Date
August 25, 2033
Authorized Company / Fabricante
Name (English)
BECTON DICKINSON DE COLOMBIA LTDA